Afinancia – Page 7 – Boston’s economy, explained with data.

Boston Biotech Leads Capital Surge Amid Policy Shifts

New Title: Boston’s Biotech Engine: How Policy Incentives Are Fueling a $2 Trillion Capital Cycle The latest wave of venture

The recent $1.35 billion acquisition by Analog Devices, solidifying its position as a deep tech leader, serves as a stark

New Title: Boston’s Bifurcation: Why Institutional Capital is Betting on Biotech Towers Over Single-Family Homes The median home value in

For investors tracking the Greater Boston ecosystem, the health and life sciences sectors are currently acting as a powerful economic

New Title: Boston’s Biotech Resilience Tested by Regulatory Friction and Macro Headwinds The valuation jump of a Cambridge robotics startup

A Cambridge robotics startup hitting an $1.1 billion valuation—backed by giants like Toyota and Nvidia—is not merely a headline; it

The continued surge in mergers and acquisitions within Greater Boston’s life sciences sector, exemplified by local headcount at companies like

New Title: Boston’s Policy Crucible: How Biotech Hypergrowth is Redefining Municipal Governance in Greater Boston The valuation of a single

The latest wave of corporate investment in Greater Boston’s life sciences sector confirms its status as a global innovation engine,